BioSpace News Archive

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Company”), today announced that its wholly owned subsidiary Aptorum Therapeutics Limited (“ATL”) has entered into a non-binding Letter of Intent and Term Sheet (“Term Sheet”) to merge (“Transaction”) its 100% subsidiary, Paths Innovation Limited.

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of Accugenix® Next Generation Sequencing for Bacterial Identification and Fungal Identification (Accugenix® NGS).

Procaps Group, S.A., a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that it will file its Form 20-F and publish its Full Year 2022 Earnings Release before May 15th.

Zymeworks Inc. today announced that management will participate in the following upcoming investor conferences.

Caira Surgical, the pioneer in radar surgical tracking for navigated and robotic joint replacement surgery, announced today that it received three new patents for its advanced radar surgical tracking and fast landmark registration technologies.

Today, Casana - the industry leader in monitoring heart health through smart toilets - announced receipt of U.S.A. Food and Drug Administration (FDA) clearance of the Heart Seat™ for measuring Heart Rate and Oxygen Saturation (SpO2).

BlueWind Medical, Ltd., the developer of a transformative implantable tibial neuromodulation therapy for Overactive Bladder (OAB), today announced results from the OASIS pivotal trial evaluating the safety and efficacy of the BlueWind System in the treatment of OAB.

Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve human health, today announced the appointment of Gabrielle ‘Gabi’ Raia to the newly created position of Senior Vice President of Discovery and Clinical Sales.

Medial EarlySign (earlysign.com), a pioneering company developing AI-based clinical predictive analytics, announced at the recent HIMSS Conference a new agreement with Roche, which will allow for EarlySign ColonFlag to be offered within the navify® Algorithm Suite from Roche Diagnostics.

Exactech announced that a new study1 that shows positive two-year outcomes for the Equinoxe® Humeral Reconstruction Prosthesis, a solution for extensive proximal humerus bone loss, has just been published in the Journal of Shoulder and Elbow Surgery.